Kirk R. Schultz

22.0k citations
214 papers · 7.5k · 5 hit papers · h-index 46

Impact in

  • Hematology top 0.05%
    • Hematopoietic Stem Cell Transplantation
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments

Papers in

Kirk R. Schultz

205 papers receiving 7.4k citations

Kirk R. Schultz's Hit Papers

EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment 2018 · 278 citations
2780+5+11Years since publication100200300400

Peers

Kirk R. Schultz
Comparison fields: 5 of 115
  • Hematology 4.6k
  • Transplantation 304
  • Genetics 907
  • Public Health, Environmental and Occupational Health 2.3k
  • Immunology 1.6k
Replace Christina Peters with:
Christina Peters Austria
Madan Jagasia United States
Bipin N. Savani United States
Karen K. Ballen United States
Yoshiko Atsuta Japan
Dietrich W. Beelen Germany
Michael A. Pulsipher United States
Frédéric Baron Belgium
Norma K.C. Ramsay United States
John E. Levine United States
Kirk R. Schultz relative to Christina Peters Austria Christina Peters's profile →
Citations per field
00.5×1.6×
Christina Peters · 1×
Citations per year

Countries citing papers authored by Kirk R. Schultz

Since Specialization
Citations

This map shows the geographic impact of Kirk R. Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirk R. Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirk R. Schultz more than expected).

Fields of papers citing papers by Kirk R. Schultz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirk R. Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirk R. Schultz. The network helps show where Kirk R. Schultz may publish in the future.

Co-authors

The 25 scholars most cited alongside Kirk R. Schultz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kirk R. Schultz Line = papers co-authored together Kirk R. Schultz links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 214 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
Hit paper breakdown →
2009442
2
Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031
Hit paper breakdown →
2014309
3 2006305
4 2010300
5
The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease
Hit paper breakdown →
2016295
6
Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report
Hit paper breakdown →
2015287
7
EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment
Hit paper breakdown →
2018278
8 2015243
9 2007178
10 2014173
11 2015167
12 2012143
13 2015124
14 2006124
15 2006123
16 2006112
17 2007103
18 2015100
19
Requirement for B cells in T cell priming to minor histocompatibility antigens and development of graft-versus-host disease.
199599
20 199493

About Kirk R. Schultz

Kirk R. Schultz is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Immunology, Pediatrics, Perinatology and Child Health and Oncology, having authored 214 papers that have together received 7.5k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (117 papers), Acute Lymphoblastic Leukemia research (74 papers), Immune Cell Function and Interaction (28 papers), Childhood Cancer Survivors' Quality of Life (25 papers), Chronic Myeloid Leukemia Treatments (24 papers), Acute Myeloid Leukemia Research (23 papers), T-cell and B-cell Immunology (21 papers) and Immunotherapy and Immune Responses (19 papers). The work is most often cited by research in Hematology (4.6k citations), Transplantation (304 citations), Genetics (907 citations), Public Health, Environmental and Occupational Health (2.3k citations) and Immunology (1.6k citations). Kirk R. Schultz has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Bruce M. Camitta, Michael J. Borowitz, Stephanie J. Lee, Steven Z. Pavletic, Nyla A. Heerema, Harland N. Sather, Paul S. Gaynon, Andrew J. Carroll, Stephen P. Hunger and Andrew L. Gilman. Their work appears in journals such as Biology of Blood and Marrow Transplantation, Blood, Bone Marrow Transplantation, Journal of Clinical Oncology and Transplantation and Cellular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact